Skip to main content
An official website of the United States government

DCEG Scientists Contribute to 2017 NIH Research Festival

, by DCEG Staff

In September 2017, DCEG investigators and fellows presented research findings at the NIH Research Festival. Stephen J. Chanock, M.D., DCEG Director, co-chaired the festival’s organizing committee alongside Susan Amara, Ph.D., Scientific Director of the National Institute of Mental Health.

During “The Cancer Moonshot” plenary session, Maria Isabel Achatz, M.D., Ph.D., discussed “Population screening for cancer predisposition genes,” and Aimée R. Kreimer, Ph.D., spoke on “One- vs two-dose HPV vaccine trial.”

Sharon A. Savage, M.D., Chief of the Clinical Genetics Branch, co-chaired a session on “Genotyping and phenotyping,” during which she spoke on “Uncovering etiology and improving patient care through characterization of cancer predisposition syndromes.” Douglas Stewart, M.D., discussed “Genotype first, phenotype second: Novel phenotype discovery in the DICER1 syndrome at the Clinical Center in the era of large-scale exome sequencing” during the same session.

In addition, several DCEG investigators and fellows presented posters at the festival.

< Older Post

Research from DCEG Study Informs New Cervical Cancer Prevention Standards

Newer Post >

New Regions of the Human Genome Linked to Skin Color Variation in Some African Populations